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Abstract 
Broad-spectrum antimicrobial agents, such as silver, are increasingly being 
formulated into medicated wound dressings in order to control colonization of wounds 
by opportunistic pathogens. Medicated wound dressings have been shown in-vitro to 
be effective against planktonic cultures, but in-vivo bacteria are likely to be present in 
biofilms, which makes their control and eradication more challenging. Recently, a 
functional wound dressing (AQUACEL® Ag+ ExtraTM (AAg+E)) has been developed 
that in addition to silver contains two agents (ethylenediaminetetraacetic acid (EDTA) 
and benzethonium chloride (BC)) designed to disrupt biofilms. Here, the efficacy of 
AAg+E is demonstrated using a biofilm model developed in an isothermal 
microcalorimeter. The biofilm was seen to remain viable in the presence of 
unmedicated dressing, silver-containing dressing or silver nitrate solution. In the 
presence of AAg+E, however, the biofilm was eradicated. Control experiments 
showed that neither EDTA nor BC alone had a bactericidal effect, which means it is 
the synergistic action of EDTA and BC disrupting the biofilm with silver being 
bactericidal that leads to the product’s efficacy. 
 
 
Key words: 
Staphylococcus aureus; biofilm; isothermal calorimetry; wound dressings; silver 
 
 3 
1. Introduction 
The process of healing of chronic cutaneous wounds is complex and may be affected 
by the presence of microorganisms (Bowler, 2002). In particular, bacterial 
contamination may slow wound healing, result in damage to surrounding tissue and 
ultimately lead to infection of the host (Landis, 2008). Progression to infection may 
also be aided by other factors including poor blood supply to the wound and the 
intrinsic virulence properties of the invading organisms (Siddiqui and Bernstein, 2010; 
Bowler et al, 2001).  
The fact that treatment of bacterial infection at the wound site has the potential 
significantly to reduce the time for wound healing has led to the development of a 
number of medicated wound dressings containing antimicrobial agents. Silver is a 
particularly widely used agent, as it shows broad antimicrobial (against both Gram-
negative and Gram-positive organisms, Miraftab et al, 2014) and anti-fungal activity 
(Bowler et al, 2005), although there is debate as to the specific efficacy of silver (Aziz 
et al, 2012; White and Cutting, 2006) and to its potential toxicity (Hermans, 2006). 
An added complexity in the treatment of chronic wound infections is that the 
organisms are frequently present as biofilms, with this form of bacterial growth being 
increasingly implicated in cases of poor wound healing (Hurlow and Bowler, 2012). 
Evidence for biofilm involvement in chronic wounds comes from macroscopic (Hurlow 
and Bowler, 2012; Metcalf and Bowler, 2013) and microscopic observation of biofilms 
(James et al., 2008; Metcalf and Bowler, 2013). A study involving in vivo wound 
models of a Staphylococcus aureus infection also showed microscopic evidence of 
biofilm formation along with a demonstration of physiological differences between 
planktonic cells and biofilm bacteria recovered from wounds (Davis et al. 2008).  
While the drivers for biofilm formation are not completely clear, experimentally it is 
usually the case that microbial biofilms show reduced antimicrobial susceptibility than 
comparable planktonic organisms (Davis et al, 2008, Percival et al, 2011). Antibiotic 
resistance has been ascribed to several mechanisms, including the production of 
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inactivating enzymes, the presence of persister cells and the protective effects of 
extracellular polymeric substances (EPS) (Smith, 2005).  
Successful treatment of chronic wound infections therefore requires development of 
next generation of medicated dressings that are efficacious against biofilms. 
AQUACEL® Ag+ ExtraTM (AAg+E) is a recently developed dressing that contains two 
agents that are known to disrupt biofilms, ethylenediaminetetraacetic acid (EDTA) 
and benzethonium chloride (BC), in addition to ionic silver as an antimicrobial agent. 
A recent cohort analysis of wound healing data involving 121 clinical cases showed 
AAg+E to result in progress towards healing in over 90% of wounds which were 
previously stalled, infected or at risk of infection and with a high suspicion of biofilm 
contamination (Metcalf et al, 2014). 
Determination of wound dressing efficacy using analytical or traditional 
microbiological methods is tricky, because of the challenges inherent in determining 
viable bacterial counts in a heterogeneous system. Isothermal microcalorimetry 
(IMC) is one technique that offers potential in this area, since it can detect the power 
resulting from bacterial growth without requiring optical clarity of the sample. We 
showed previously how IMC can be used to quantitate wound dressing efficacy 
(Gaisford et al, 2009; Said et al, 2014) against planktonic cultures of two common 
wound pathogens. To use IMC to investigate the efficacy of AAg+E against biofilms, 
however, requires development of a biofilm model. Hence, the specific aim of this 
work was to develop a biofilm model suitable for use with IMC and to use the model 
to explore the efficacy of AAg+E. 
 
2. Material and Methods 
Ethylenediaminetetraacetic acid (EDTA), benzethonium chloride (BC) and silver 
nitrate (AgNO3) were purchased from Sigma (UK) and used as received. Wound 
dressings, AQUACEL® (AH), AQUACEL® Ag (AAgH) or AQUACEL® Ag Extra 
(AAg+E) were supplied by ConvaTec Ltd. The wound dressings, all comprised of 
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sodium carboxymethylcellulose fibres, differ in that AH has no antimicrobial agent 
while AAgH contains ionic silver and AAg+E contains ionic silver, EDTA and BC. 
The challenge organism, Staphylococcus aureus NCIMB 9518, was grown overnight 
in nutrient broth (NB; Oxoid Ltd) for 16h at 37 oC. Cells were then harvested, washed 
in phosphate buffered saline (PBS), resuspended in 15 %v/v glycerol at an organism 
density of 108 cfu/ml and frozen in aliquots (1 mL) over liquid nitrogen (Beezer et al, 
1976; Cosgrove, 1979). Aliquots were stored under liquid nitrogen until required. 
Previous experience (data not shown) has indicated that organisms can be stored for 
over 6 years in this frozen state and remain viable post thawing with less than 1% 
decrease in viability.  
Ampoules were prepared by adding molten agar (300 µL, Agar No. 3, Oxoid), which 
was allowed to set. Tryptone soya broth (TSB, 1 mL) was added to prepared 
ampoules and inoculated with S. aureus to a final population density of 1x106 cfu/mL. 
The ampoules were then sealed and incubated at 37 oC with agitation for 24 hours. 
Thereafter, the ampoules were opened and the TSB was carefully poured out. The 
ampoules were gently rinsed with sterile distilled water a minimum of five times to 
ensure effective removal of planktonic cells. Fresh, sterile TSB (1 mL) and where 
required wound dressing (3.3 mg), EDTA (0.14% w/v), BC (0.4% w/v) or AgNO3 (1 x 
10-4 M) was then added to the ampoules, which were hermetically sealed and placed 
into calorimeters.  
Cell counts were determined after each calorimetric experiment. After removal of 
TSB and extensive rinsing, as above, fresh PBS was added to ampoules, which were 
then sealed. Ampoules were then briefly vortexed before being sonicated for a period 
of 5 minutes. Colony counts were determined by serially diluting the PBS from the 
ampoules and spread plating onto iso-sensitest agar. Colonies were counted 
following 16h incubation at 37 oC. 
Calorimetric data were recorded with a 2277 Thermal Activity Monitor (TAM; TA 
Instruments Ltd, UK) operated at 37 oC. Data capture was initiated exactly 30 min 
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post inoculation with the dedicated software package Digitam 4.1 (1 data point every 
10 s, amplifier setting 300 µW). The instrument was calibrated periodically by the 
electrical substitution method. Data were analysed using Origin 8.1 (Microcal 
Software Inc). 
 
3. Results and Discussion 
Although not discussed here, it was not possible to culture a biofilm directly onto the 
glass walls of the ampoule. Rather, the agar layer was necessary to encourage 
biofilm attachment and growth. A similar effect has been noted in ecological research 
where a twofold increase in the accumulation of diatoms (phytoplanktonic algae) was 
seen on a surface when unenriched agar was added (Stevenson, 1983). The 
rationale in that study was the use of agar to ‘simulate mucilage of immigrating 
organisms’, in other words to create a ‘slimy’, polymeric conditioning film. In relation 
to in vivo correlation it has been suggested that the use of agar simulates a microbial 
colonisation of a moist surface, similar to wounds (Daeschlein, 2010).  
The physiology of cells in biofilms is distinct from those in planktonic culture because 
of their sessile nature and differences in exposure to nutrients and gases in their 
microenvironment (Stewart and Franklin, 2008). Diffusion is the main mechanism of 
delivery of solutes to biofilm clusters (Stewart, 2003) and so concentration gradients 
exist that depend on the thickness of the biofilm. It follows that delivery of 
antimicrobial agents will similarly be rate limited by this diffusion mechanism, and 
their efficacy may be reduced relative to planktonic cultures (up to a 1000 fold 
decrease in susceptibility has been reported, Stewart and Costerton, 2001).  
Similarly, the power produced by an established biofilm will differ from that of a 
planktonic culture. As has been discussed in the literature (Braissant et al, 2010; 
Said et al, 2014) the power output from planktonic cultures will show a series of 
exothermic peaks and troughs with time as the organisms utilise the available 
nutrients to increase in number. Integration of the power data with respect to time 
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gives a plot of cumulative heat versus time, which is comparable to the standard 
growth curves determined with optical density (OD) readings.  
Typical power-time data for S. aureus biofilms are shown in Figure 1. Biofilms were 
found not to give as repeatable data as planktonic cultures. Similar variability was 
seen in a study by Astasov-Frauenhoffer et al (2012). However, the degree of 
variability was small enough to permit study of the efficacy of the dressing. It is 
apparent that there is an exothermic peak initially, followed by a smaller, but 
persistent, exothermic power. It is assumed that the initial peak represents either 
growth of planktonic cells released from the biofilm or growth and metabolism within 
the biofilms themselves. The power then resolves to a non-zero baseline, which is 
assumed to be associated with biofilm metabolism.  
The presence of the initial exotherm is surprising. Following 24 hours incubation, the 
putative biofilm samples were extensively rinsed in order to remove planktonic cells. 
Each rinsing can be considered as a 1:1 dilution as the volume of diluent used was 
equivalent to that of the original growth medium in the culture. As such, very little or 
no power, or at least a significant delay in onset of power signals, would be expected 
from planktonic cells as these would have been diluted down to undetectable levels 
(given that the lower limit of detection for IMC is approximately 1x105 – 1x106 cfu/mL, 
Said et al, 2014).  
Cell counts for biofilm samples suggest a potential explanation. Immediately following 
preparation (i.e. before being loaded into the calorimeter) the average cell count was 
4x107 cfu/mL. After 24 h in the calorimeter, the average cell count had increased to 
1x108 cfu/mL. This suggests that cell division continues within the biofilm, presumably 
until the available nutrients and/or gases in the fresh medium are exhausted, after 
which the system reverts to a stasis metabolism. An alternative explanation is that 
since rinsing will disturb the isotonic balance of the system, the biofilm responds by 
dispersing bacteria from the film as a survival response. These bacteria then grow as 
a planktonic population. 
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The corresponding cumulative heat plot for the biofilm is shown in Figure 2 (all further 
data are shown as cumulative heat plots for familiarity and ease of comparison with 
OD data). 
Previously (Said et al, 2014) we showed that AgNO3 at a concentration of 1 x 10-4 M 
was bactericidal against planktonic S. aureus. Figure 3 shows the growth curves for 
planktonic and biofilm cultures in the presence of this silver concentration. As 
expected, no growth is seen in planktonic culture, but the biofilm culture shows 
growth following an initial delay. The average cell count following the calorimetric 
experiment was 1.5 x 107 cfu/mL, not much lower than that recorded for the 
untreated biofilm, which confirms that biofilm formation confers on the participant 
organisms a significant degree of protection against antimicrobial agents. 
The implication of this finding is that a wound dressing containing silver alone might 
be less effective against a biofilm culture, and this effect is indeed observed 
experimentally, Figure 4. Dressing alone (AH) did not inhibit growth, while silver-
containing dressing (AAgH) only delayed growth (the same effect noted above in the 
silver nitrate experiments).  
Successful eradication of an established biofilm requires delivery of agents to disrupt 
biofilm structure in addition to an antimicrobial compound. This is the formulation 
strategy behind AAg+E and the data in Figure 4 show a significant reduction in 
growth with this dressing. The average cell count following exposure to AAg+E was 2 
x 104 cfu/mL, so the dressing can be deemed to be bactericidal in nature because it 
induced a 3 log reduction in viable cells relative to the control. 
The question then remains as to the relative contributions of the components in 
AAg+E to the overall efficacy of the dressing. Biofilms were exposed to solutions 
containing only AgNO3, only EDTA and BC or all three components (Figure 5). In all 
cases a small amount of AH (i.e. plain dressing) was included, the intention being to 
imitate the action of a dressing containing only these components. It is apparent that 
EDTA and BC cause an initial delay but then growth is seen which is identical to the 
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control. We noted previously that the presence of AH can alter the kinetics of growth 
(Said et al, 2014), possibly because the hydrofiber network can sequester planktonic 
bacteria, changing the rate of supply of nutrients and altering local pH. It is also 
possible that the hydrofiber itself can cause physical disruption of a biofilm. An effect 
on growth rate in the presence of AH is seen in Figure 4. (Silver nitrate is seen to 
inhibit growth for at least 10h, after which growth similar to the control is seen. In 
neither case therefore do these components act to inhibit the biofilm. When they are 
added in combination, however, a reduction in growth is seen, which confirms the 
hypothesis that it is the combination of biofilm disrupters and an antimicrobial agent 
working in synergy that is necessary for efficacy.  
The effect of EDTA has been attributed to its properties as a metal chelator, since the 
chelation of divalent cations that are important in ensuring the structural integrity of 
cells causes disruption and prolonged exposure may result in a biocidal effect (Banin 
et al., 2005). Certain divalent cations have also been indicated in the structural 
integrity of the biofilm EPS matrix (Banin et al., 2005; Percival et al., 2005) and 
sequestration of these cations may result in dispersal of the biofilm.  
EDTA may also play a role in the delivery of silver to the bacteria. Since silver is 
contained in the dressing in its ionic form, delivery to its site of action will be affected 
both by the concentration of free silver in solution and the relative association 
constants between silver and components in solution and the bacterial cell wall. It is 
likely that binding to EDTA affects the relative positions of these association 
constants, and since the silver appears to have faster action in the presence of EDTA 
the data imply the association constant of silver with EDTA is fast, ensuring silver 
ions are rapidly removed from the dressing, but not as strong as the association 
constants of silver with the cells. 
BC, on the other hand, is a surfactant. In high concentrations BC has antiseptic and 
anti-infective properties that have been shown to have anti-biofilm activity against 
oral fungal biofilms (Ichikawa et al., 2008), but the concentrations achieved from 
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AAg+E are below the MIC. Thus, BC acts to reduce surface tension, affecting biofilm 
architecture and cell-cell interactions (Davey et al., 2003), promoting the activity of 
silver when delivered with EDTA. 
4. Summary 
 
A biofilm model was developed that enabled the use of IMC to test the efficacy of an 
anti-biofilm wound dressing. It was shown that a broad spectrum antimicrobial agent 
alone was not effective against the biofilm but that when biofilm disrupting agents 
were included in the dressing bactericidal action was seen. 
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Figure 1: Power-time data for biofilms grown on agar, showing the level of 
reproducibility for three samples.
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Figure 2: Power-time data for the control biofilm (bottom) and corresponding 
growth curve (top) 
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Figure 3: Growth curves for planktonic and biofilm cultures in the presence of 
1 x 10-4 M AgNO3. 
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Figure 4: Growth curves for biofilms in the presence of AH, AAgH and AAg+E. 
 
 20 
0 5 10 15 20
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Cu
m
m
u
la
tiv
e
 
he
a
t /
 
J
Time / h
AgNO3
EDTA + BC
AgNO3 + EDTA + BC
Biofilm control
 
Figure 5: Growth curves for biofilm alone and in the presence of AgNO3, EDTA 
+ BC and AgNO3 + EDTA + BC. 
 
 
 
